TuHURA Biosciences
HURA
22 hedge funds and large institutions have $1.48M invested in TuHURA Biosciences in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
8% less funds holding
Funds holding: 24 → 22 (-2)
26% less capital invested
Capital invested by funds: $1.99M → $1.48M (-$515K)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.9K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$19.4K |
| 3 |
Millennium Management
New York
|
+$5.76K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.76K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$1.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$127K |
| 2 |
Renaissance Technologies
New York
|
-$61.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$24K |
| 4 |
Two Sigma Investments
New York
|
-$18K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$16K | -18 | Closed |
|
27
Two Sigma Advisers
New York
| – | -$15K | -17 | Closed |
|
HURA Hedge Fund Activity: Q1 2022 in Review
22 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2022, worth a combined $1.48M — down 26% from $1.99M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of HURA and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $20.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $127K sold.
- 22 institutional investors held TuHURA Biosciences (HURA) as of Q1 2022, down from 24 in Q4 2021.
- Funds reported $1.48M of TuHURA Biosciences stock for Q1 2022, down 26% quarter-over-quarter.
- 3 funds opened new TuHURA Biosciences positions in Q1 2022 and 5 closed out, a net change of -2 holders.
- The largest TuHURA Biosciences buyer in Q1 2022 was Geode Capital Management, an estimated $20.9K added.
- The largest TuHURA Biosciences seller in Q1 2022 was Citadel Advisors, an estimated $127K sold.
Based on aggregated 13F filings for Q1 2022.